awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28602112-1EED5BDF-7C6C-455D-A8E0-DB1BDEE32621
Q28602112-1EED5BDF-7C6C-455D-A8E0-DB1BDEE32621
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28602112-1EED5BDF-7C6C-455D-A8E0-DB1BDEE32621
A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP)
P2860
Q28602112-1EED5BDF-7C6C-455D-A8E0-DB1BDEE32621
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28602112-1EED5BDF-7C6C-455D-A8E0-DB1BDEE32621
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ab2e6682d7ff5d43d0aa3f56bfbac7f1d8e9dd0
P2860
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.